Safety of SSRIs in Pregnancy
Depression occurs in up to 20% of pregnant women, and the use of selective serotonin reuptake inhibitors (SSRIs) in these women has been increasing.1 Maternal depression has itself been associated with intrauterine growth problems and low birth weight, so the risks of exposure to antidepressants during pregnancy must be weighed against the risks of untreated depression, which also include self-harm, poor bonding and poor parenting. SSRIs available in the US for treatment of depression include citalopram (Celexa, and others), escitalopram (Lexapro), fluoxetine (Prozac, and others), paroxetine (Paxil, and others) and sertraline (Zoloft).
Benefits of Ovid Insights Include:
- Consolidated email digests of the latest research in your favorite topics
- A personalized dashboard of your topics all on one page
- Tools to bookmark and share articles of interest
- Ability to customize and save your own searches
Register with Ovid Insights »